Georgetown Lombardi, Washington's only National Cancer Institute-designated Comprehensive Cancer Center, works with other institutions — MedStar Health and the John Theurer Cancer Center — to broaden its research capacity.
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center, seeks to prevent, treat and cure cancers by linking scientific discovery, expert and compassionate patient care, quality education and partnership with the community — guided by the principle of cura personalis, “care for the whole person.” Georgetown Lombardi, in partnership with John Theurer Cancer Center, is the research engine driving clinical cancer care at MedStar Georgetown University Hospital, an ACOS-accredited 609-bed teaching hospital, and the other hospitals in the D.C. Metro area collaborating within the MedStar Georgetown Cancer Institute.
Georgetown University President John J. DeGioia discusses the significance of Georgetown Lombardi's research:
Established in 1970, the Georgetown Lombardi Comprehensive Cancer Center is named for legendary football coach Vince Lombardi, who was treated for cancer at Georgetown University Hospital. What began as a small clinic treating cancer patients has grown into a state-of-the-art cancer center housing more than 240,000 square feet of clinic and research space. The director of the Cancer Center is Louis M. Weiner, MD.
In 1974, Georgetown Lombardi became the 16th National Cancer Institute (NCI)-designated Comprehensive Cancer Center in the country. Today, we remain the only center with this designation in the Washington, D.C., area.